Fujirebio and Agappe Enter into an Agreement on Business Collaboration in the Field of CLIA Based Immunoassay

Contributed by: Business Wire

Logo

Tags

Oncology

Health

Consumer

Infectious Diseases

Baby/Maternity

General Health

Cardiology

Agappe Agreement

More Like This

Fujirebio and Sysmex Enter into Basic Agreement on Business Collaboration in the Field of Immunoassay

Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics

Fujirebio and Sysmex Expand CDMO Partnership into the Field of Neurodegenerative Diseases under Their Immunoassay Collaboration

Fujirebio Launches the Fully Automated Lumipulse® G GFAP Assay for Research Use Only and Further Strengthens its Neuro Test Menu

Fujirebio and Sysmex Sign Agreement for the Supply of Reagent Raw Materials in the Field of Immunoassay

Fujirebio Announces Strategic Collaboration with Stanford Medicine to Advance Infectious Disease Research

Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G sTREM2 Assay for Research Use Only

PR Newswire associated0

Fapon Highlights Innovative IVD Total Solutions and Localization Services at MEDICA 2024